Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Genetics | Diagnos. | Mental | Nutrition | Molecular | Cell Bio | Inflamm. | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.0 | 1.0 | 1.1 | 1.6 | 0.6 | 0.3 | 1.0 | 1.9 | 2.0 | 1.1 | 0.5 | 1.6 | 0.1 |
| United States | 1.0 | 1.1 | 1.1 | 1.3 | 0.8 | 0.9 | 1.1 | 1.4 | 0.5 | 0.7 | 0.6 | 0.7 | 1.2 | 0.7 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.1 | 2.1 | 1.1 | 1.3 | 0.8 | 0.6 | 0.8 | 0.9 | 0.9 | 1.8 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.7 | 0.5 | 1.1 | 1.9 | 0.7 | 1.0 | 2.0 | 0.8 | 0.7 | 0.8 |
| Turkey | 1.3 | 1.2 | 0.9 | 0.6 | 0.4 | 0.5 | 1.4 | 0.9 | 0.7 | 0.5 | 0.6 | 1.6 | 0.4 | 1.1 | 1.7 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.7 | 0.9 | 2.1 | 0.8 | 0.6 | 0.4 | 0.7 | 2.0 | 0.4 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.7 | 1.2 | 0.6 | 0.8 | 2.1 | 0.8 | 0.3 | 0.3 | 0.1 | 3.7 | 0.5 | 0.6 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 0.5 | 1.1 | 0.8 | 1.4 | 0.4 | 0.3 | 0.6 | 1.0 | 1.1 | 1.6 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.5 | 2.0 | 0.3 | 0.9 | 0.6 | 0.8 | 0.6 | 0.4 | 1.1 | 0.4 | 0.2 | 1.7 |
| Poland | 1.3 | 1.4 | 0.6 | 0.6 | 0.3 | 0.7 | 0.6 | 1.2 | 1.1 | 0.5 | 0.2 | 1.1 | 1.2 | 1.5 | 1.4 |
Studies9,761–9,780 of 20,708
All studies
Polycystic Ovary Syndrome - Functional Investigation and Clinical Application
Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome
A single cut-off value of anti-Müllerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women
A lipid profile study in polycystic ovary syndrome women
Serum Anti-Mullerian Hormone (AMH) Levels are Effective in Predicting the Diagnosis of Four Polycystic Ovarian Syndrome (PCOS) Phenotypes
Analysis of blood parameters and clinical features in women with pilonidal sinus disease: Is there a link between the disease and polycystic ovary syndrome?
Role of Chromium Versus Metformin Supplementations as Adjuvant for Ovulation Induction By Clomiphene Citrate in Infertile Patients With Polycystic Ovary Syndrome : Randomized Controlled Trial
<i>I have lost my Identity:</i> Disease Management Challenges of the Women Suffering from Polycystic Ovary Syndrome (PCOS)
Spontaneous Pregnancies in Polycystic Ovary Syndrome (PCOS) Patients with a Low Starch/Low Dairy Diet: A Retrospective Case Series
RF24 | PSUN116 Once-weekly semaglutide delays a late phase gastric emptying of solid meal measured by repeated scintigraphic imaging in obese women with PCOS
Analysis of peculiarities of miscarriage in women of reproductive age with different PCOS phenotypes
Impact of Vitamin D Deficiency on the Pathogenesis of Polycystic Ovary Syndrome
Inter relationship of sympathetic reflex response and oxidative stress in polycystic ovary syndrome
Evaluation of Serum MiR-184 and MiR-326 Expression in PCOS Subjects: Correlation with PCOS Related Parameters
Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence
Polycystic ovary syndrome and pregnancy - review
Inflammatory markers in lean Polycystic Ovary Syndrome subjects are not associated with the spectrum of dyslipidemia
Advanced therapy of overweight or obese polycystic ovary syndrome: a prospective study
HLA-B*0702 class-I allele, anti-FSH, anti-LH, and vitamin D3: Potential links with polycystic ovary syndrome in women of Erbil city, Iraq
Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS